HealthCap Invests in AMRA Medical to Accelerate Global Growth in Quantitative MRI

Contributed by: Business Wire

Logo

Images

HealthCap Invests in AMRA Medical to Accelerate Global Growth in Quantitative MRI

Business Wire embedded0

Tags

Research

Medical Devices

Clinical Trials

Health Technology

Biotechnology

General Health

Pharmaceutical

Health

Science

Other Science

MRI-based technologies

More Like This

New Year, New Solutions: AMRA Medical Continues Commitment to Innovation & Data-Driven Excellence

AMRA Medical Recognized as one of TIME Magazine’s ‘World’s Top HealthTech Companies’

Setting the Standard: AMRA Medical Recognized as one of TIME Magazine’s ‘World’s Top HealthTech Companies’

AMRA® Profiler 4 provides rapid and precise body composition measurements in relation to normative data, contextualizing insights at the individual patient level, with high accuracy. (Graphic: Business Wire)

AMRA Medical Secures European Medical Device Regulation Certificate for AMRA® Profiler 4, Highlighting Yet Another Regulatory Win

AMRA's muscle biomarkers - Research study explore changes in lean muscle volume (LMV), muscle fat fraction (MFF), and muscle fat infiltration (MFI)

Decoding Duchenne Muscular Dystrophy: MRI Study Explores the Relationship Between AMRA’s Muscle Biomarkers and Functional Changes in Individuals With DMD

AMRA® BCP Scan available at Prescan

AMRA Medical Introduces AMRA® BCP Scan in the Netherlands Through a Strategic Partnership with Prescan, a National Preventative Health Leader

A rapid, non-invasive, clinical surveillance for CachExia, sarcopenia, portal hypertension, and hepatocellular carcinoma in end-stage liver disease: the ACCESS-ESLD study protocol (Photo: Business Wire)

Baseline Enrollment Completed for AMRA Medical and Linköping University’s Landmark Liver Disease Study

AMRA Medical - Measuring Muscles with Quantitative MRI

Measuring Muscles with Quantitative MRI: New Study Published in Neurology Expands the Evidence for Using MRI Biomarkers in SBMA

Credit: Collaboration with Dr. Ian J Neeland, University Hospitals Cleveland. Data from NCT03038620 (ClinicalTrials.gov identifier) analysed with AMRA® Researcher

AMRA Medical’s Muscle Composition Analysis Used to Evaluate the Effect of Liraglutide Treatment in Obesity